Jackson Square Capital’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History

Jackson Square Capital’s Portfolio SRRA Stock Details SRRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-101,000	Closed	-$5.55M	–	154
2022 Q2	$5.55M	Buy	101,000 +12,175	+14%	+$639K	2.35%	11
2022 Q1	$2.85M	Buy	+88,825	New	+$2.55M	0.89%	37
2021 Q4	–	Sell	-9,152	Closed	-$201K	–	197
2021 Q3	$201K	Buy	+9,152	New	+$183K	0.07%	171

Other funds holding SRRA

Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return

Jackson Square Capital's SRRA Position: Q3 2022 in Review

Jackson Square Capital sold out of Sierra Oncology, Inc. Common Stock (SRRA) in Q3 2022, closing a stake of 101,000 shares — an estimated $5.55M sold.

Jackson Square Capital first reported a position in SRRA in Q3 2021 and held it in 3 quarters. The position peaked at $5.55M in Q2 2022. 1 fund tracked by Wall St. Rank holds SRRA as of Q3 2022.

Jackson Square Capital reported no remaining Sierra Oncology, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
Jackson Square Capital sold 101,000 Sierra Oncology, Inc. Common Stock shares in Q3 2022, an estimated $5.55M.
Jackson Square Capital first reported a position in Sierra Oncology, Inc. Common Stock in Q3 2021 and held it in 3 quarters.
Jackson Square Capital's Sierra Oncology, Inc. Common Stock position peaked at $5.55M in Q2 2022.
1 fund tracked by Wall St. Rank held Sierra Oncology, Inc. Common Stock as of Q3 2022.

Based on Jackson Square Capital's 13F filing for Q3 2022, filed 13 Oct 2022.